Medirom Healthcare Technologies (MRM) Gains from Investment Securities (2019 - 2023)
Historic Gains from Investment Securities for Medirom Healthcare Technologies (MRM) over the last 5 years, with Q4 2023 value amounting to $3988.1.
- Medirom Healthcare Technologies' Gains from Investment Securities fell 502.73% to $3988.1 in Q4 2023 from the same period last year, while for Dec 2023 it was $3988.1, marking a year-over-year decrease of 502.73%. This contributed to the annual value of $5.9 million for FY2024, which is 593.55% down from last year.
- Latest data reveals that Medirom Healthcare Technologies reported Gains from Investment Securities of $3988.1 as of Q4 2023, which was down 502.73% from $4199.2 recorded in Q4 2022.
- Medirom Healthcare Technologies' 5-year Gains from Investment Securities high stood at $6502.9 for Q4 2020, and its period low was $3988.1 during Q4 2023.
- Over the past 5 years, Medirom Healthcare Technologies' median Gains from Investment Securities value was $4780.1 (recorded in 2019), while the average stood at $4949.4.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 3603.91% in 2020, then tumbled by 2041.81% in 2022.
- Medirom Healthcare Technologies' Gains from Investment Securities (Quarter) stood at $4780.1 in 2019, then soared by 36.04% to $6502.9 in 2020, then decreased by 18.86% to $5276.6 in 2021, then fell by 20.42% to $4199.2 in 2022, then fell by 5.03% to $3988.1 in 2023.
- Its last three reported values are $3988.1 in Q4 2023, $4199.2 for Q4 2022, and $5276.6 during Q4 2021.